Jin Won Kim et al. suggests that it is more accurately for CD3+ cells to predict the prognosis for patients with GC than other T-cell subtypes (CD4+ or CD8+), because CD3+ TILs, which includes both CD4+ and CD8+ cells, may reveal more convincing information about the host-tumor immune response [29]. Here, CD4 is linked to gastric cancer.